MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 133 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $5,836,000 | +6.3% | 472,000 | +2.1% | 0.16% | -5.7% |
| Q1 2015 | $5,490,000 | +4.8% | 462,100 | -0.3% | 0.18% | -7.4% |
| Q4 2014 | $5,239,000 | +30.6% | 463,600 | +1.5% | 0.19% | +9.9% |
| Q3 2014 | $4,010,000 | +20.5% | 456,700 | 0.0% | 0.17% | +22.0% |
| Q2 2014 | $3,329,000 | +25.9% | 456,700 | -13.0% | 0.14% | +11.0% |
| Q1 2014 | $2,645,000 | -15.3% | 524,800 | -10.4% | 0.13% | -26.2% |
| Q4 2013 | $3,123,000 | – | 585,800 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |